Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Clinical Medicine|April 30, 2021
Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib TreatmentRitu Shrestha, Prashanth Prithviraj, Kim R Bridle, et al.Current Oncology (Toronto, Ont.)|July 2, 2021
Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem CellsRitu Shrestha, Kim R Bridle, Lu Cao, et al.Nano Letters|April 12, 2013
Multifunctional hierarchically assembled nanostructures as complex stage-wise dual-delivery systems for coincidental yet differential trafficking of siRNA and paclitaxelMahmoud Elsabahy, Ritu Shrestha, Corrie Clark, et al.Journal of Polymer Science. Part A, Polymer Chemistry|November 28, 2012
pH-Triggered reversible morphological inversion of orthogonally-addressable poly(3-acrylamidophenylboronic acid)-block-poly(acrylamidoethylamine) micelles and their shell crosslinked nanoparticlesJiong Zou, Shiyi Zhang, Ritu Shrestha, et al.Bioconjugate Chemistry|March 1, 2012
Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injuryRitu Shrestha, Yuefei Shen, Kevin A Pollack, et al.Nucleic Acid Therapeutics|April 6, 2013
Efficient protection and transfection of small interfering RNA by cationic shell-crosslinked knedel-like nanoparticlesYuefei Shen, Huafeng Fang, Ke Zhang, et al.Journal of Bacteriology|December 16, 2015
Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant ReceptorDisha Bhattacharjee, Michael B Francis, Xicheng Ding, et al.International Journal of Molecular Sciences|February 15, 2022
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder CancerLu Cao, Kim R Bridle, Ritu Shrestha, et al.Biomacromolecules|March 21, 2013
Degradable cationic shell cross-linked knedel-like nanoparticles: synthesis, degradation, nucleic acid binding, and in vitro evaluationSandani Samarajeewa, Aida Ibricevic, Sean P Gunsten, et al.Gene Therapy|March 23, 2018
Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinomaBijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, et al.Pageof 4